Sharon Anne Jackson

Title: Innovator Spotlight: Sharon Anne Jackson

Introduction

Sharon Anne Jackson is a notable inventor hailing from Chadds Ford, Pennsylvania. With an impressive portfolio consisting of three patents, she has made significant contributions to the pharmaceutical field, particularly in the development of innovative compounds that assist in medical advancements.

Latest Patents

Sharon's latest patents focus on novel cyclic compounds linked by a heterocyclic ring system. These compounds are designed to serve as antagonists of the platelet glycoprotein IIb/IIIa complex. Her inventions aim to create pharmaceutical compositions that utilize these cyclic compounds for the inhibition of platelet aggregation, thus playing a crucial role in the prevention of blood clots. A representative compound from her innovative work is cyclo-(D-Val-N(Me)Arg-Gly-Asp-�5-aminomethyl!-2-furoate), which showcases the complexity and utility of her research.

Career Highlights

Currently, Sharon is a prominent member of the Dupont Merck Pharmaceutical Company, where she applies her expertise to drive forward innovative solutions in the pharmaceutical sector. Her research is central to advancing treatment options that can enhance patient care and increase the efficacy of medications.

Collaborations

Throughout her career, Sharon has collaborated with distinguished colleagues, including Shaker Ahmed Mousa and Anju Parthasarathy. These partnerships underscore the collaborative nature of scientific research, allowing for the integration of diverse expertise to tackle complex challenges in medicine.

Conclusion

Sharon Anne Jackson’s contributions to the field of pharmaceuticals, through her patents and collaborative efforts, highlight her as a key inventor in the industry. Her innovative cyclic compounds hold promise for significant medical applications, demonstrating her commitment to advancing scientific knowledge and therapeutic solutions.